Nanodigmbio @ the 19th International Genomics Congress Shenzhen · Clinical Application of Reproductive Health (ICG19·RH)

01 Grand Event of the conference

On March 16-17, 2024, the two-day 19th International Congress on Genomics: Clinical Applications for Reproductive Health (ICG19·RH) was successfully concluded in Shenzhen. With the promulgation of the Program for the Development of Chinese Women (2021-2030) and the Program for the Development of Chinese Children (2021-2030), the strategic position of establishing and improving a birth defect prevention and control system covering all stages before marriage, pre-marriage, pregnancy, newborn and children, and giving priority to the healthy development of women and children has once again been emphasized. It is even more important to carry out the Healthy China Action to provide comprehensive and full-cycle health services for the people, especially to protect the health of women and children and improve the quality of China's newborn population. In order to achieve the big goal of universal health, the International Genomics Congress: The clinical application of reproductive health has always been guided by the big people's livelihood and big science, adhering to the mission of "gene technology for the benefit of mankind", focusing on the clinical application and development of multi-omics technology in the field of maternal and child health, building a high-standard international exchange platform, and escorting life and health with the power of gene technology.

The conference invited 50+ guests, a total of nearly 30 related reports and forums, the conference gathered domestic and foreign industry leaders, research forces, precision medicine experts and scholars, an all-round discussion of the future global maternal and child health development faced by the opportunities and challenges, calling on all sectors of society to work together to prevent and control birth defects.

02 Nanodigmbio wonderful moment

At this exhibition, Nanodigmbio brought NEXome -Series Panel to the exhibition site, which is Nanodigmbio on the basis of NEXome Core Panel, according to different application scenarios, launched a total of 4 products, forming the NEXome series Panel. These products are different in terms of coverage area and variation detection, and users can choose according to their needs. Many participants have come to consult the product application related content. In addition, many participants had a strong interest in other related products and services of Nanodigmbio, and the sales and marketing team of Nanodigmbio have carefully answered them. At the same time, the field team also shared insights with other peers and field experts. This exchange and exchange has been a profound growth for both sides and benefited a lot!

At this point, the 19th International Congress of Genomics · Clinical Application of Reproductive Health (ICG19·RH) in Shenzhen has come to an end, and mountains and rivers have met, we will see you next time!